Skip to main content
Search
Cancel
Back to Biocom California
Membership
Advocacy
Programs
Events
News & Insights
About
About the Conference
Why Attend
Partnering Meetings
Agenda
Speakers
Company Presenters Announced
Register
Investor Registration
Sponsors
Lodging
About the Conference
Why Attend
Partnering Meetings
Agenda
Speakers
Company Presenters Announced
Register
Investor Registration
Sponsors
Lodging
CEO Cornerstone
Committees
Diversity, Equity & Inclusion
Career Hub
Member Community
About
About Us
Our Team
Board of Directors
Careers
Contact
Our Locations
San Diego
Greater Los Angeles
Bay Area
Sacramento
Washington, D.C.
Tokyo
Home
/
Conferences
/
Global Life Science Partnering & Investor Conference
/
Speakers
Conference Speakers
Conference Speakers and Panelists | 2025
Devang Bhuva
Senior Vice President, Corporate Development
Gilead Sciences
Kate Bingham, DBE
Managing Partner
SV Health Investors
Sarah Boyce
President & CEO
Avidity Biosciences
Matthew Bresnahan, J.D.
Partner
Wilson Sonsini
Matt Bush
Partner
Latham & Watkins
Jeremy Caldwell, Ph.D.
Partner
Red Tree Venture Capital
John Carroll
Editor & Founder
Endpoints News
Jennifer Giottonini Cayer
Chief Business Officer, Pulmocide; Board Member, Biocom California; Board Member
UCSD Moore’s Cancer Center
Mira Chaurushiya, Ph.D.
Managing Director
Westlake Village BioPartners
Ben Cravatt, Ph.D.
Professor & Gilula Chair, Chemical Biology
The Scripps Research Institute
Thomas Daniel, M.D.
Director, Scripps Research; Chair & Founder
Life Science Cares San Diego
Kalli Dircks
Managing Director
Morgan Stanley
Adam Feire, Ph.D.
SVP, Head of Business Development / M&A and External Innovation
Biogen
Richard Glynne, Ph.D.
Venture Partner; President & CSO, Inception Therapeutics Discovery Engine
Versant Ventures
Corey Goodman, Ph.D.
Managing Partner
venBio Partners
Luba Greenwood
Managing Partner, Binney Street Capital Venture Fund
Dana-Farber Cancer Institute
Sonia Gupta
Partner
Goldman Sachs
Jason Hafler
Managing Director
Sanofi Ventures
Kent Hawryluk
President & CEO
MBX Biosciences
Richard Heyman, Ph.D.
Venture Partner
ARCH Ventures
Kate Hillier
Partner
Cooley
Tony Ho
Chief Scientific Officer & Senior Science Partner
Pivotal Life Sciences
Tim Ingrassia
Co-Chair, Global Mergers & Acquisitions
Goldman Sachs
Joel Klappenbach, Ph.D.
Executive Director, Worldwide Business Development
Pfizer
Selina Koch, Ph.D.
Executive Editor
BioCentury
Jim Krenn
Partner & Co-Chair, Emerging Companies + Venture Capital Group
Morrison Foerster
John Lepore, M.D.
CEO, ProFound Therapeutics; CEO-Partner
Flagship Pioneering
Jay Lichter, Ph.D.
Managing Director
Avalon Ventures
Kevin Lind
President & CEO
Longboard Pharmaceuticals
Tim Luker, Ph.D.
Vice President, Venture Science, West Coast USA Head, Corp BD
Eli Lilly and Company
Bill Martin, Ph.D.
Global Therapeutic Area Head, Neuroscience
Johnson & Johnson Innovative Medicine
Mark McKenna
Founder, Chairman & CEO
Mirador Therapeutics
Grace Han McMahon
AVP and Head, Pacific BD&L
Merck
Shlomo Melmed, M.D.
Dean
Cedars-Sinai Medical Center
Detlev Mennerich, Ph.D.
Global Head
Boehringer Ingelheim Venture Fund
Thomas Miller
Co-Founder & CEO
Iambic Therapeutics
Brett Monia, Ph.D.
CEO
Ionis Pharmaceuticals
Bob More
Managing Director
Alta Partners
Mitchell Mutz, Ph.D.
Entrepreneur Partner
Vivo Capital
Amir Nashat, Ph.D.
Board Chair, Paratus Sciences; Managing Partner
Polaris Partners
Carolyn Ng, Ph.D.
Partner & Managing Director
TPG Life Sciences Innovations
Carole Nuechterlein
Head
Roche Venture Fund
Daniel O’Connell, M.D., Ph.D.
Partner
Novo Ventures
Deborah Palestrant, Ph.D.
Partner & Executive Chair, 4:59 Initiative
5AM Ventures
Mark Paris, Ph.D.
Executive Director, Oncology Search and Evaluation
Daiichi Sankyo
Steven Paul, M.D.
Board Chair, FNIH; Venture Partner
Third Rock Ventures
Jeremy Quirk
VP BD&L Commercial Portfolio
GSK
Hunter Reed
Vice President – Life Science, Alexandria Venture Investments
Alexandria Real Estate Equities
Mary Rozenman, Ph.D.
CFO & CBO
insitro
Alicia Russo
Partner & Co-Chair, Intellectual Property Transactions Group
Venable
Camille Samuels
Director
Venrock Boards
James Schaeffer, Ph.D.
Vice President, Business Strategy
PhenoTarget
Adam Simpson
Venture Partner
Frazier Life Sciences
Ken Song, M.D.
Chairman, President & CEO
Candid Therapeutics
Avi Spier, Ph.D.
Executive Director, Search & Evaluation
Novartis
Jay Stamatis
Vice President, Head of Business Development and Acquisitions
AbbVie
Tari Suprapto, Ph.D.
Director, Search & Evaluation (West)
Novo Nordisk
Marc Tessier-Lavigne, Ph.D.
CEO
Xaira Therapeutics
Richard Tillyer, Ph.D.
Global Head, Discovery, Product Development & Supply
Johnson & Johnson Innovative Medicine
Matt Tremblay, Ph.D.
Chief Executive Officer
Blackbird Laboratories
Issei Tsukamoto, Ph.D.
SVP, Head of Business Development
Astellas Pharma
Court Turner
Partner
LYZZ Capital
Omari Wise
Vice President, Business Development
Amgen
Bradley Wolff
Senior Managing Director
Evercore
Asish Xavier, Ph.D.
Vice President, Venture Investments
Johnson & Johnson Innovation – JJDC
Rieko Yajima, Ph.D.
Director, Drug Discovery Innovation
SPARK at Stanford